Soleno Therapeutics Ratios (2013-2019) | SLNO

Ratios Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019
Profitability
Gross Margin 18.18%77.32%77.33%-6.30%-3.13%-2,450.00%-21.28%21.66%21.13%-4,100.00%
EBT Margin 273.91%280.17%276.29%295.07%275.93%179.54%-11,031.82%-3,138.14%-1,288.66%-1,451.82%-953.69%-114,750.00%-598.18%-645.95%-517.74%-296,500.00%
EBIT Margin 173.91%180.42%176.29%195.07%175.93%79.54%-11,027.27%-3,138.14%-1,288.66%-1,452.24%-953.69%-114,750.00%-598.18%-645.95%-518.11%-296,800.00%
EBITDA Margin 173.91%180.42%176.29%195.07%175.93%79.54%-11,027.27%-3,138.14%-1,288.66%-1,452.24%-953.69%-114,750.00%-598.18%-645.95%-518.11%-296,800.00%
Operating Margin 173.91%180.42%176.29%195.07%175.93%79.54%-11,027.27%-3,138.14%-1,288.66%-1,452.24%-953.69%-114,750.00%-598.18%-645.95%-518.11%-296,800.00%
Net Margin 273.91%280.17%276.29%295.07%275.93%179.54%-11,031.82%-3,138.14%-1,333.20%-1,178.00%-953.69%-60,800.00%-1,945.59%-920.89%-317.74%-91,300.00%
FCF Margin 232.86%131.19%172.69%167.82%67.07%-8,227.27%-2,783.51%-1,097.57%-1,297.92%-895.53%-202,000.00%-847.42%-944.99%-825.28%-299,100.00%
Efficiency
Inventory Average 0.16M0.24M0.33M0.46M0.60M0.71M0.74M0.51M
Assets Average 5.05M9.23M9.42M8.03M7.74M8.80M7.46M6.92M6.94M19.71M32.12M28.38M32.70M37.68M34.84M32.09M36.99M41.01M36.50M31.43M
Equity Average -26.78M-11.25M-9.47M-4.46M0.97M4.53M4.22M4.16M4.57M16.79M28.42M24.95M25.01M24.92M19.43M15.02M22.31M27.02M18.74M14.36M
Invested Capital -20.20M-42.38M-11.09M-11.30M3.39M2.56M4.09M5.83M2.61M5.71M3.44M30.14M26.69M23.21M26.82M23.02M15.84M14.21M30.41M23.63M13.84M14.88M
Asset Utilization Ratio -0.82-0.40-0.31-0.240.080.120.130.150.150.040.03
Leverage & Solvency
Interest Coverage Ratio -1.74-1.80-1.76-1.95-1.76-0.80-0.00M0.00M
Debt to Equity -0.41-0.01-1.44-2.980.27
Debt Ratio 8.820.011.260.530.11
Equity Ratio -21.55-24.99-1.33-1.12-0.87-0.180.390.620.470.690.620.890.880.880.690.630.470.460.700.610.410.52
Times Interest Earned -1.74-1.80-1.76-1.95-1.76-0.80-0.00M0.00M
Valuation
Enterprise Value -1.99M-1.27M-0.76M-1.21M-0.06M2.14M33.79M13.58M12.12M17.38M11.82M15.43M8.77M10.04M23.17M16.29M19.27M0.90M3.27M33.66M36.01M13.56M46.01M73.47M36.46M
Market Capitalization 10.10M43.32M21.11M16.84M22.88M18.32M17.94M14.19M12.77M33.71M23.84M24.92M18.00M18.13M46.26M46.25M36.65M65.42M88.97M47.69M
Return Ratios
Return on Sales 2.83%2.83%2.25%2.86%3.97%6.56%-20.02%-13.56%-12.98%-9.77%-7.20%-4.80%-4.46%
Return on Capital Employed -1.37%-0.84%2.20%-5.25%-2.67%-2.25%-2.38%-2.34%-1.98%-0.43%-0.27%-0.33%-0.39%
Return on Assets -1.84%-1.15%-1.24%-1.60%-1.57%-1.59%-1.63%-1.44%-1.10%-0.21%-0.12%-0.15%-0.11%
Return on Equity 0.35%0.95%1.24%2.87%-12.58%-3.09%-2.88%-2.39%-1.67%-0.25%-0.14%-0.17%-0.14%